BridgeBio Pharma earnings missed by $0.18, revenue fell short of estimates

  • Investing.com
BridgeBio Pharma earnings missed by $0.18, revenue fell short of estimates

Investing.com - BridgeBio Pharma (NASDAQ: BBIO ) reported second quarter EPS of $-0.98, $0.18 worse than the analyst estimate of $-0.80. Revenue for the quarter came in at $1.6M versus the consensus estimate of $2.99M.

BridgeBio Pharma's stock price closed at $32.00. It is up 133.92% in the last 3 months and up 220.64% in the last 12 months.

BridgeBio Pharma saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See BridgeBio Pharma's stock price’s past reactions to earnings here.

According to InvestingPro, BridgeBio Pharma's Financial Health score is "fair performance".

Check out BridgeBio Pharma's recent earnings performance , and BridgeBio Pharma's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles